|
|
||||||||
J Thorac Cardiovasc Surg 2004;127:738-745
© 2004 The American Association for Thoracic Surgery
Surgery for congenital heart disease |
a Department of Anesthesiology, Milwaukee, Wis USA
b Pediatric Critical Care Medicine, Milwaukee, Wis USA
c Cardiothoracic Surgery, Milwaukee, Wis USA
d Pediatric Cardiology, Milwaukee, Wis USA
e Children's Hospital of Wisconsin, Milwaukee, WI, USA
f Medical College of Wisconsin, Milwaukee, Wis, USA
Presented in part at the annual meeting of the American Society of Anesthesiologists, New Orleans, La, October 2001.
Received for publication March 18, 2003; revisions received April 22, 2003; revisions received May 19, 2003; accepted for publication June 18, 2003.
* Address for reprints: George Hoffman, MD, Pediatric Anesthesiology and Critical Care Medicine, Children's Hospital of Wisconsin, #735, 9000 West Wisconsin Ave, Milwaukee, WI 53226, USA
ghoffman{at}mcw.edu
OBJECTIVES: Hemodynamic vulnerability after the Norwood procedure for hypoplastic left heart syndrome results from impaired myocardial function, and critical inefficiency of parallel circulation. Traditional management strategies have attempted to optimize circulatory efficiency by using arterial oxygen saturation (SaO2) as an index of pulmonary/systemic flow balance, attempting to maintain SaO2 within a theoretically optimal critical range of 75% to 80%. This optimal range of SaO2 has not been verified clinically, and strategies targeting SaO2 may be limited by the fact that SaO2 is a poor predictor of systemic oxygen delivery. We have previously reported higher venous saturation (SvO2), lower arteriovenous oxygen content difference, lower systemic vascular resistance, lower pulmonary/systemic flow ratio, and improved survival with the perioperative use of phenoxybenzamine and continuous monitoring of SvO2. In this investigation, we tested the hypothesis that intense afterload reduction with phenoxybenzamine would modify the SvO2-SaO2 relationship by preventing deterioration of systemic oxygen delivery at high SaO2.
METHODS: Seventy-one consecutive neonates undergoing the Norwood procedure with and without phenoxybenzamine were studied. Perioperative hemodynamic management targeted SvO2 greater than 50%. Hemodynamic data were prospectively acquired for 48 hours postoperatively and analyzed to assess the effect of phenoxybenzamine on the relationship between SaO2 and SvO2 and other hemodynamic indices. Sixty-two patients received phenoxybenzamine 0.25 mg/kg on cardiopulmonary bypass; 9 who did not served as controls.
RESULTS: In control patients, SvO2 peaked at an SaO2 of 77%, with reduced SvO2 at SaO2 > 85% and SaO2 < 70% (P < .01), while arteriovenous oxygen content difference increased with SaO2 greater than 80% (P < .001). In patients receiving phenoxybenzamine, the SvO2 increased linearly with SaO2 greater than 65% (P < .001), and arteriovenous oxygen content difference was constant at all SaO2 (P = ns). The SvO2 was higher, and the arteriovenous oxygen content difference lower, across the whole SaO2 range with phenoxybenzamine (P < .0001).
CONCLUSIONS: A critical range of SaO2 for optimizing systemic oxygen delivery was confirmed in control patients, and was effectively eliminated by phenoxybenzamine, specifically by eliminating the systemic hypoperfusion associated with high SaO2. This effect allows higher SaO2 to be included in a rational hemodynamic strategy to improve systemic oxygen delivery in the early postoperative management of patients receiving intense afterload reduction with phenoxybenzamine. The predictability of SvO2 from SaO2 is low in both groups, emphasizing the importance of SvO2 measurement in these patients.
This article has been cited by other articles:
![]() |
Rebuttal by Aschner and Liske J Appl Physiol, June 1, 2008; 104(6): 1839 - 1839. [Full Text] [PDF] |
||||
![]() |
E. Ebenroth Point:Counterpoint: Hypoxia is/is not the optimal means of reducing pulmonary blood flow in the preoperative single ventricle heart J Appl Physiol, June 1, 2008; 104(6): 1835 - 1836. [Full Text] [PDF] |
||||
![]() |
O. J. Liakopoulos, J. K. Ho, A. Yezbick, E. Sanchez, C. Naddell, G. D. Buckberg, R. Crowley, and A. Mahajan An Experimental and Clinical Evaluation of a Novel Central Venous Catheter with Integrated Oximetry for Pediatric Patients Undergoing Cardiac Surgery Anesth. Analg., December 1, 2007; 105(6): 1598 - 1604. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Tweddell, N. S. Ghanayem, K. A. Mussatto, M. E. Mitchell, L. J. Lamers, N. L. Musa, S. Berger, S. B. Litwin, and G. M. Hoffman Mixed Venous Oxygen Saturation Monitoring After Stage 1 Palliation for Hypoplastic Left Heart Syndrome Ann. Thorac. Surg., October 1, 2007; 84(4): 1301 - 1311. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Joffe, C. M.T. Robertson, A. Nettel Aguirre, I. M. Rebeyka, R. S. Sauve, and The Western Canadian Complex Pediatric Therapies P Mortality after neonatal cardiac surgery: Prediction from mean arterial pressure after rewarming in the operating room J. Thorac. Cardiovasc. Surg., August 1, 2007; 134(2): 311 - 318. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Stuth Phenoxybenzamine Is Indicated in Treatment of Hypoplastic Left Heart Syndrome: Pro Anesth. Analg., August 1, 2007; 105(2): 307 - 309. [Full Text] [PDF] |
||||
![]() |
J. A. DiNardo Phenoxybenzamine Is Indicated in Treatment of Hypoplastic Left Heart Syndrome: Con Anesth. Analg., August 1, 2007; 105(2): 310 - 311. [Full Text] [PDF] |
||||
![]() |
N. A. Guzzetta Phenoxybenzamine in the Treatment of Hypoplastic Left Heart Syndrome: A Core Review Anesth. Analg., August 1, 2007; 105(2): 312 - 315. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Li, G. Zhang, B. W. McCrindle, H. Holtby, T. Humpl, S. Cai, C. A. Caldarone, A. N. Redington, and G. S. Van Arsdell Profiles of hemodynamics and oxygen transport derived by using continuous measured oxygen consumption after the Norwood procedure J. Thorac. Cardiovasc. Surg., February 1, 2007; 133(2): 441 - 448. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. S. Ghanayem, R. D.B. Jaquiss, J. R. Cava, P. C. Frommelt, K. A. Mussatto, G. M. Hoffman, and J. S. Tweddell Right Ventricle-to-Pulmonary Artery Conduit Versus Blalock-Taussig Shunt: A Hemodynamic Comparison Ann. Thorac. Surg., November 1, 2006; 82(5): 1603 - 1610. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. McElhinney and D. F. Teitel From Theory to Practice: Optimizing the Efficiency of an Inefficient Circulation Circulation, September 19, 2006; 114(12): 1226 - 1228. [Full Text] [PDF] |
||||
![]() |
J. Li, G. Zhang, H. M. Holtby, B. W. McCrindle, S. Cai, T. Humpl, C. A. Caldarone, W. G. Williams, A. N. Redington, and G. S. Van Arsdell Inclusion of oxygen consumption improves the accuracy of arterial and venous oxygen saturation interpretation after the Norwood procedure J. Thorac. Cardiovasc. Surg., May 1, 2006; 131(5): 1099 - 1107. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Stieh, G. Fischer, J. Scheewe, A. Uebing, P. Dutschke, O. Jung, R. Grabitz, H. J. Trampisch, and H. H. Kramer Impact of preoperative treatment strategies on the early perioperative outcome in neonates with hypoplastic left heart syndrome J. Thorac. Cardiovasc. Surg., May 1, 2006; 131(5): 1122 - 1129. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Oishi, A. Azakie, C. Harmon, R. K. Fitzgerald, A. Grobe, J. Xu, K. Hendricks-Munoz, S. M. Black, and J. R. Fineman Nitric oxide-endothelin-1 interactions after surgically induced acute increases in pulmonary blood flow in intact lambs Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H1922 - H1932. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Hoffman, K. A. Mussatto, C. L. Brosig, N. S. Ghanayem, N. Musa, R. T. Fedderly, R. D.B. Jaquiss, and J. S. Tweddell Systemic venous oxygen saturation after the Norwood procedure and childhood neurodevelopmental outcome J. Thorac. Cardiovasc. Surg., October 1, 2005; 130(4): 1094 - 1100. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Cua, R. R. Thiagarajan, R. Taeed, T. M. Hoffman, L. Lai, J. Hayes, P. C. Laussen, and T. F. Feltes Improved Interstage Mortality With the Modified Norwood Procedure: A Meta-Analysis Ann. Thorac. Surg., July 1, 2005; 80(1): 44 - 49. [Abstract] [Full Text] [PDF] |
||||
![]() |
U Theilen and L Shekerdemian The intensive care of infants with hypoplastic left heart syndrome Arch. Dis. Child. Fetal Neonatal Ed., March 1, 2005; 90(2): F97 - F102. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |